Here are the benefits of proactively promoting this web site to your patients:

  • Supports your patient by not forcing them into a visit just to pick up more eye drops

  • Referring your patient to this web site should reduce any desire for them to shop elsewhere or search online, risking the complete loss of future sales

  • You receive a commission on every sale your patient makes

  • Reduced stock holding helps lower the amount of cash tyied up in stock

  • Encourages your patient to maintain the ‘treatment’ regimen you recommend buy buying at  3, 6 or 10-months supply at a time

  • You simply sell (or give a sample) the first supply and advise your patient they can either return to the practice or visit this web site


HydraMed increases ocular comfort

HydraMed (HA + TSP) remains up to 84% longer on the pre-corneal surface than HA alone*

  • Strong bio and mucoadhesive properties prolong retention times

  • Longer residency allows for longer relief and dose reduction

Reducing osmolarity

  • The hypotonic formulation creates an immediate isotonic effect

  • Immediate comfort upon instillation by correcting osmotic imbalance

Screen Shot 2020-04-16 at 16.52.10.jpg

HydraMed helps to stabilise the tear film and increase Tear Break-up Time (TBUT)

HydraMed shows good efficacy in stabilising the tear film after only 28 days of use. 

Patients treated using HydraMed (2 drops/3 times per day) shows a significant increase of their average TBUT compared with the base value after only 28 days of use.

Screen Shot 2020-04-16 at 16.52.10.jpg

HydraMed improves the score of epithelial microvilli conditions by 48% more than HA alone

The HydraMed group showed a 5 fold increased mean improvement compared with the HA group.

Score moved 1.9 points towards normal in HydraMed Group

  • Equal to 56.5% (statistically significant) improvement compared to baseline.


HydraMed showed more than 28% reduction of epithelial damage compared with HA only based eye drops

Objective signs - Absolute Values

After 60 days of use a 0.1 point improvement on the average score (5.3%) of the objective signs was observed in the sodium hyaluronate group. In the HydraMed user group after the same period of use the lowest score (1.9) for objective signs was observed. This equates to a statistically significant 0.9 point improvement, 33.3% compared with the base level.